These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1094308)

  • 1. Protective tumour cell ghosts with intact membrane markers.
    Davies II; Nicklin MG; Augustin R
    Nature; 1975 Jul; 256(5512):49-50. PubMed ID: 1094308
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization of mice against transplantable tumor.
    Kay ER
    Experientia; 1973 Jun; 29(6):710-1. PubMed ID: 4718721
    [No Abstract]   [Full Text] [Related]  

  • 3. Passive immunotherapy of mice bearing Ehrlich ascites tumor expressing human, membrane-bound placental alkaline phosphatase.
    Barka T; Henderson S; van der Noen HM
    Tumour Biol; 2000; 21(3):145-52. PubMed ID: 10754465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer preventive effects of whole cell type immunization against mice Ehrlich tumors.
    Aysan E; Bayrak OF; Aydemir E; Telci D; Sahin F; Yardimci C; Muslumanoglu M
    Asian Pac J Cancer Prev; 2013; 14(6):3515-9. PubMed ID: 23886138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenicity of cancer-associated and cancer-specific antigens].
    del Pozo AM; Valladares Y; Alvarez-Rodríguez Y; Alvarez-Noves J
    Rev Esp Oncol; 1982; 29(4):685-700. PubMed ID: 6927369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of passively administered antibodies on the development of Ehrlich tumor in mice].
    Strzelecka G
    Ann Acad Med Stetin; 1980; 26():387-400. PubMed ID: 7186780
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumour immunoprotection by an immunobacterial lectin approach.
    Verloes R; Kanarek L; Atassi G
    Eur J Cancer (1965); 1976 Nov; 12(11):877-88. PubMed ID: 991898
    [No Abstract]   [Full Text] [Related]  

  • 8. Topography of concanavalin A receptors on Ehrlich ascites tumour cells as demonstrated by thin sections and freeze etching.
    Roth J; Wagner M; Meyer HW
    Pathol Eur; 1974; 9(1):31-42. PubMed ID: 4608187
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumour immunoprophylaxis exerted by the antimicrococcus immunity. II. Influence on the proliferation of murine plasmacytoma (MOPC 176) and Ehrlich carcinoma cells.
    Verloes R; Atassi G; Dumont P; Kanarek L
    Eur J Cancer (1965); 1978 Dec; 14(12):1321-9. PubMed ID: 738337
    [No Abstract]   [Full Text] [Related]  

  • 10. Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood.
    Garnis S; Lala PK
    Immunology; 1978 Mar; 34(3):487-99. PubMed ID: 640717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascitic versus solid growth of Ehrlich ascites tumor influenced by immunological factors.
    Culo F; Allegretti N; Marusić M
    Oncology; 1978; 35(1):15-21. PubMed ID: 625393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody as carrier of chlorambucil.
    Ghose T; Nigam SP
    Cancer; 1972 May; 29(5):1398-400. PubMed ID: 4553765
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of the antigenic specificity of cell subpopulations of Ehrlich ascites cancer].
    Lobko GN; Porubova GM
    Eksp Onkol; 1989; 11(1):69-71. PubMed ID: 2466634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the cellular and viral antigens of a BALB-c myeloma and murine leukemia virus.
    Krueger RG; Miller GC
    J Natl Cancer Inst; 1974 Oct; 53(4):997-1004. PubMed ID: 4372374
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of ascites tumour with cytolytic serum obtained by double immunization.
    Mihaescu GH; Micu N; Popp I; Comisel V; Mihaescu I
    Neoplasma; 1974; 21(3):297-302. PubMed ID: 4424781
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
    Saha S; Mondal S
    Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastogenic response of lymphoid cells to tumor cells or tumor membrane extracts in vitro.
    Poon SP; Cauchi MN
    Cancer Res; 1973 Nov; 33(11):2677-82. PubMed ID: 4270637
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection of mice from malignant tumor implants by enucleated tumor cells.
    Sethi KK; Brandis H
    J Natl Cancer Inst; 1974 Oct; 53(4):1175-6. PubMed ID: 4372368
    [No Abstract]   [Full Text] [Related]  

  • 19. [Different immunological factors in the therapy of an experimental tumor].
    Nicolin A; Frontini E; Olivani P
    Boll Ist Sieroter Milan; 1971; 50(4):295-8. PubMed ID: 5163498
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.
    Forni G; Comoglio PM
    Br J Cancer; 1974 Oct; 30(4):365-9. PubMed ID: 4447779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.